2-Hydroxy-1,2-di(thiophen-2-yl)ethan-1-one, 97%, 5g

Methyl 3-((tert-butoxycarbonyl)amino)thiophene-2-carboxylate, 95.0%, 10g

Potassium 2-fluoro-5-formylphenyltrifluoroborate, 98%, 5g

4-{5-[(Dimethylamino)sulfonyl]-2,3-dihydro-1H-indo-1-yl}-4-oxobutanoic acid, 95.0%, 1g

3-(5,6-Dimethyl-1H-benzimidazol-1-yl)propanoic acid hydrochloride, 95.0%, 2.5g

methyl 3-amino-1-(2,2-difluoroethyl)-1H-pyrazole-4-carboxylate, 1g

2-Methyl-5-nitro-3-pyridinecarboxylic acid, 95.0%, 5g

1,10-Dibromodecane, 98.0%, 25g

Ethyl Undecanoate>98.0%(GC)25mL

tert-Butyl (4R)-4-[(E)-3-bromoprop-1-enyl]-2,2-dimethyl-oxazolidine-3-carboxylate, 97% mix TBC as stabilizer, 100mg

2-Phenylphenol Sodium Salt Tetrahydrate>98.0%(HPLC)25g

1,4-DIMETHYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBALDEHYDE, 95.0%, 250mg

Combretastatin A4, 98.0%, 1g